GlobeImmune, Inc. (GBIM) Financial Statements (2023 and Earlier)

Company Profile

Business Address 1450 INFINITE DRIVE
LOUISVILLE, CO 80027
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,90116,812
Cash and cash equivalents9,90116,812
Other current assets1,1901,000
Total current assets:11,09117,812
Noncurrent Assets
Property, plant and equipment210456
Other noncurrent assets206 
Other undisclosed noncurrent assets 100
Total noncurrent assets:415556
TOTAL ASSETS:11,50618,368
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7752,410
Accounts payable234573
Accrued liabilities5411,259
Employee-related liabilities 578
Deferred revenue and credits3,4513,341
Other undisclosed current liabilities (578)
Total current liabilities:4,2255,172
Noncurrent Liabilities
Liabilities, other than long-term debt4,2927,592
Deferred revenue and credits4,1217,443
Other liabilities172149
Total noncurrent liabilities:4,2927,592
Total liabilities:8,51812,765
Stockholders' equity
Stockholders' equity attributable to parent2,9885,603
Common stock66
Additional paid in capital228,454228,302
Accumulated deficit(225,472)(222,705)
Total stockholders' equity:2,9885,603
TOTAL LIABILITIES AND EQUITY:11,50618,368

Income Statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
Revenues
(Revenue, Net)
6,4585,966
Cost of revenue
(Cost of Goods and Services Sold)
(2,360)(4,992)
Gross profit:4,098974
Operating expenses(9,225)(11,694)
Other undisclosed operating income2,3604,901
Operating loss:(2,767)(5,819)
Nonoperating expense (1,863)
Investment income, nonoperating (1,903)
Interest and debt expense (8,578)
Net loss attributable to parent:(2,767)(16,261)
Preferred stock dividends and other adjustments (7,174)
Net loss available to common stockholders, diluted:(2,767)(23,435)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
Net loss:(2,767)(16,261)
Comprehensive loss, net of tax, attributable to parent:(2,767)(16,261)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: